HEMOSTASIS COAGULATION RESEARCH INHIBITORS SYNTHETIC REVERSIBLE INHIBITORS
Pepbloc NAPAP
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/lyophilise.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/RUO.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/stockage_2_8C.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/fabricant.jpg)
![](https://www.cryopep.fr/wp-content/uploads/resource/images/pictos/distributeur.jpg)
Formulation : N-α-(2-naphthylsulfonylglycyl)-4-amidino-(D, L)-phénylananin pipéridid acétate (NAPAP)
MW(Da) : 581.7
Potent and selective competitive inhibitors of thrombin.
![Cryopep](https://www.cryopep.fr/wp-content/uploads/resource/generated/thumbnail/Generique.jpg)
Reference | 6-INH-NAPAP-5 |
---|---|
Presentation | Vial |
Format | 5 mg |
Quote |
Price list, safety data sheets and notices are accessible to our registered customers.
Reference | Presentation | Format | Quote | Product sheet |
---|---|---|---|---|
6-INH-NAPAP-5 | Vial | 5 mg |